Gubra A/S (CPH:GUBRA)

Revenue by Segment

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
CRO	192.52M	220.22M	168.56M	130.62M	155.03M
CRO Growth	-12.58%	30.65%	29.04%	-15.74%	4.59%
Biotech	2.44B	45.52M	36.45M	68.76M	100.30M
Biotech Growth	5269.36%	24.90%	-46.99%	-31.45%	316.55%
Total	2.64B	265.74M	205.01M	199.38M	255.33M
Total Growth	892.25%	29.63%	2.82%	-21.91%	48.19%

Revenue by Geography

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Denmark	37.00M	43.00M	33.00M	-	-
Denmark Growth	-13.95%	30.30%	-	-	-
Germany	-	49.00M	44.00M	-	-
Germany Growth	-	11.36%	-	-	-
Other	10.94M	6.91M	7.95M	4.32M	9.14M
Other Growth	58.43%	-13.10%	84.04%	-52.78%	34.67%
United States	2.51B	101.00M	86.00M	-	-
United States Growth	2386.14%	17.44%	-	-	-
Europe (excluding Denmark and Germany)	-	65.63M	31.28M	-	-
Europe (excluding Denmark and Germany) Growth	-	109.84%	-	-	-
Europe (Excluding Germany)	77.20M	-	-	-	-
North America (excluding United States)	669.00K	204.00K	2.78M	-	-
North America (excluding United States) Growth	227.94%	-92.67%	-	-	-
Europe	-	-	-	122.13M	176.44M
Europe Growth	-	-	-	-30.78%	97.72%
North America	-	-	-	72.93M	69.74M
North America Growth	-	-	-	4.58%	-8.56%
Total	2.64B	265.74M	205.01M	199.38M	255.33M
Total Growth	892.25%	29.63%	2.82%	-21.91%	48.19%

Source: S&P Global Market Intelligence.